Open AccessThe Effects of CoronaVac (Sinovac) and BNT162b2 (BioNTech/ Pfizer) Vaccination on Oncologic <sup>18</sup>F-FDG PET/CT Studies
Author(s) -
Hüseyin Şan,
Engin Alagöz
Publication year - 2022
Publication title -
molecular imaging and radionuclide therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.292
H-Index - 7
eISSN - 2147-1959
pISSN - 2146-1414
DOI - 10.4274/mirt.galenos.2022.86570
Subject(s) - hypermetabolism , medicine , lymph node , nuclear medicine , lymph , pathology
BioNTech (Pfizer) and CoronaVac (Sinovac) vaccines are two of the most administered coronavirus disease-2019 (COVID-19) vaccines worldwide. Vaccination against severe acute respiratory syndrome-coronavirus-2 has caused a diagnostic challenge in oncological 18 F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) studies. The aim of our study was to evaluate the 18 F-FDG PET/CT findings of the two most commonly administered vaccines worldwide.